Inotec AMD Makes the MedTech50 for Innovative Medical Technology

Recognised as a Top 50 trailblazer creating original technology for the healthcare and medical sectors


[Cambridge, UK – 28 July, 2021] – Inotec AMD, Ltd. is pleased to announce it ranked 34 in the MedTech50, recognised as one of the UK’s most innovative medical technology creators for 2021. The award honours companies helping diagnose and treat conditions mainly in a clinical setting. It acknowledges the top 50 UK firms blazing a trail by creating original technology for the healthcare and medical sectors.

Inotec received accolades for its NATROX® Oxygen Wound Therapy product, which can help heal patients with chronic wounds using the natural healing properties of oxygen. Chronic wounds pose a significant problem both on patient quality of life and costs to healthcare systems worldwide1. NATROX® Therapy is an innovative, easy-to-use device clinically proven to stimulate healing2.

“We’re honoured to be recognised among fellow forward-thinking companies finding unique ways to help people,” said Craig Kennedy, CEO of Inotec. “We feel NATROX® is a winner because it can transform people’s lives. It’s gratifying others are acknowledging what a life-changing product it is. We strongly believe everyone deserves a chance to heal.”

The final MedTech50 ranking was decided by a combination of an independent judging panel and a public vote on the shortlist of companies which attracted around 1,300 votes. See the Top 50 here.

# # #

About Inotec AMD Ltd.

Inotec AMD, Ltd. is a specialist wound care company based in Cambridge, England. Formed specifically to introduce new technologies to healthcare professionals worldwide and promote faster, better healing to patients, the company is positioning NATROX® to be an integral part of global wound care treatment regimes in the coming years. To learn more, visit: natroxwoundcare.com.

References

  1. Gottrup, F. 2020. Portable, practical and effective: clinical benefits of NATROX® topical oxygen therapy. Journal of Wound Care May 2020, 29(5):53.
  2. Serena TE, Bullock NM, Cole W et al. Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care 2021; 30: Suppl.5 S7-14.
Inotec makes Medtech 50